Chemomab Therapeutics (CMMB) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts CMMB Hot Sheet
Join SI Premium – FREE
Chemomab Therapeutics (NASDAQ: CMMB) reported Q3 EPS of $0.01, $0.07 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Chemomab Therapeutics (CMMB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investors push Seer, Inc. to disclose go-private timeline
- Active options: NFLX HTZ MSTR NBIS PLTR SNDK CRWV MSFT ONDS ORCL CSCO
- Sandisk targets mid-to-high teens revenue growth through FY2030
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
